Prognostic value of biochemical recurrence following treatment with curative intent for prostate cancer: a systematic review
T Van den Broeck, RC Van Den Bergh, N Arfi, T Gross… - European urology, 2019 - Elsevier
Context In men with prostate cancer (PCa) treated with curative intent, controversy exists
regarding the impact of biochemical recurrence (BCR) on oncological outcomes. Objective …
regarding the impact of biochemical recurrence (BCR) on oncological outcomes. Objective …
Management of patients with node-positive prostate cancer at radical prostatectomy and pelvic lymph node dissection: a systematic review
G Marra, M Valerio, I Heidegger, I Tsaur… - European urology …, 2020 - Elsevier
Context Optimal management of prostate cancer (PCa) patients with lymph node invasion at
radical prostatectomy and pelvic lymph node dissection still remains unclear. Objective To …
radical prostatectomy and pelvic lymph node dissection still remains unclear. Objective To …
Outcomes of Primary Lymph Node Staging of Intermediate and High Risk Prostate Cancer with 68Ga-PSMA Positron Emission Tomography/Computerized …
JW Yaxley, S Raveenthiran, FX Nouhaud… - The Journal of …, 2019 - auajournals.org
Purpose: The majority of men who undergo pelvic lymph node dissection at radical
prostatectomy have benign lymph node histology. The aim of this study was to assess the …
prostatectomy have benign lymph node histology. The aim of this study was to assess the …
Adjuvant and salvage radiotherapy after radical prostatectomy in prostate cancer patients
G Gandaglia, A Briganti, N Clarke, RJ Karnes… - European urology, 2017 - Elsevier
Abstract Context Prostate cancer (PCa) patients found to have adverse pathologic features
following radical prostatectomy (RP) are less likely to be cured with surgery alone. Objective …
following radical prostatectomy (RP) are less likely to be cured with surgery alone. Objective …
Application of next-generation imaging in biochemically recurrent prostate cancer
Background Biochemical recurrence (BCR) following primary interventional treatment
occurs in approximately one-third of patients with prostate cancer (PCa). Next-generation …
occurs in approximately one-third of patients with prostate cancer (PCa). Next-generation …
Multicenter external validation of a nomogram for predicting positive prostate-specific membrane antigen/positron emission tomography scan in patients with prostate …
L Bianchi, P Castellucci, A Farolfi, M Droghetti… - European Urology …, 2023 - Elsevier
Background A nomogram has recently been developed to predict 68 Ga-labeled prostate-
specific membrane antigen (PSMA)-11 positron emission tomography (PET)/computed …
specific membrane antigen (PSMA)-11 positron emission tomography (PET)/computed …
The role of prostate-specific antigen persistence after radical prostatectomy for the prediction of clinical progression and cancer-specific mortality in node-positive …
Background A complete biochemical response (BR) immediately after surgery could be
considered an indicator of optimal cancer control after radical prostatectomy (RP). Objective …
considered an indicator of optimal cancer control after radical prostatectomy (RP). Objective …
Prostate-specific membrane antigen positron emission tomography–detected oligorecurrent prostate cancer treated with metastases-directed radiotherapy: role of …
SGC Kroeze, C Henkenberens… - European urology …, 2021 - Elsevier
Abstract Background Approximately 40–70% of biochemically recurrent prostate cancer
(PCa) is oligorecurrent after prostate-specific membrane antigen (PSMA) positron emission …
(PCa) is oligorecurrent after prostate-specific membrane antigen (PSMA) positron emission …
The role of adjuvant radiotherapy in pathologically lymph node‐positive prostate cancer
BACKGROUND Postoperative management of prostate cancer with lymph node
involvement (LNI) is controversial. Retrospective evidence supports the selective use of …
involvement (LNI) is controversial. Retrospective evidence supports the selective use of …
Performance of [68Ga] Ga-PSMA 11 PET for detecting prostate cancer in the lymph nodes before salvage lymph node dissection: a systematic review and meta …
S Kimura, M Abufaraj, F Janisch, T Iwata… - Prostate Cancer and …, 2020 - nature.com
Background Salvage lymph node dissection (sLND) for nodal recurrence in prostate cancer
(PCa) patients with biochemical recurrence (BCR) is still not recommended in current …
(PCa) patients with biochemical recurrence (BCR) is still not recommended in current …